Barriers and facilitators of exploiting the potential of value-added medicines

Volume: 20, Issue: 3, Pages: 229 - 236
Published: Apr 29, 2020
Abstract
Pharmaceutical research and development (R&D) is costly and only a minority of patients can access innovative medicines due to affordability constraints. Value-added medicines (VAMs) can offer potential benefits at significantly lower R&D costs.VAMs may address different health care needs and problems, including off-label use of medicines, poor patient adherence, problems related to polypharmacy, need for home and/or personalized health care...
Paper Details
Title
Barriers and facilitators of exploiting the potential of value-added medicines
Published Date
Apr 29, 2020
Volume
20
Issue
3
Pages
229 - 236
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.